Cel-Sci
CVM
#9935
Rank
A$55.81 M
Marketcap
A$6.98
Share price
5.41%
Change (1 day)
-79.26%
Change (1 year)

Earnings for Cel-Sci (CVM)

Earnings in 2025 (TTM): -A$38.28 Million

According to Cel-Sci 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$39.64 Million, an increase over its 2023 earnings that were of -A$45.25 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cel-Sci from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$38.28 Million-3.43%
2024 -A$39.64 Million-12.41%
2023 -A$45.25 Million-12.87%
2022 -A$51.94 Million-3.42%
2021 -A$53.78 Million13.44%
2020 -A$47.41 Million11.28%
2019 -A$42.6 Million179.81%
2018 -A$15.23 Million-48.72%
2017 -A$29.69 Million-16.23%
2016 -A$35.44 Million-23.63%
2015 -A$46.41 Million-5.47%
2014 -A$49.1 Million198.49%
2013 -A$16.45 Million
2010 -A$19.2 Million
2004 -A$6.49 Million12.38%
2003 -A$5.78 Million-16.59%
2002 -A$6.93 Million-59.28%
2001 -A$17 Million23.17%
2000 -A$13.8 Million20.12%
1999 -A$11.49 Million13.24%
1998 -A$10.15 Million-20%
1997 -A$12.69 Million46.55%
1996 -A$8.66 Million34.88%
1995 -A$6.42 Million2.38%
1994 -A$6.27 Million68%
1993 -A$3.73 Million78.57%
1992 -A$2.09 Million180%
1991 -A$0.75 Million25%
1990 -A$0.6 Million-0%
1989 -A$0.6 Million-71.43%
1988 -A$2.09 Million-0%
1987 -A$2.09 Million-46.15%
1986 -A$3.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Curis
CRIS
-A$48.58 Million 31.68%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-A$9.88 Million-73.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.29 B-33,443.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-A$0.21 Billion 458.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.64 B-7,266.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
A$48.33 B-131,127.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.24 B-768.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$14.16 Million-61.62%๐Ÿ‡บ๐Ÿ‡ธ USA